Hummingbird Bioscience and Merck Enter Collaboration to Evaluate HMBD-001 In Squamous Non-Small Cell Lung Carcinoma

Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 mAb, in combination with cetuximab, an anti-EGFR mAb, in sqNSCLC HMBD-001 used as monotherapy and in combination with cetuximab has been shown to effectively inhibit tumor growth across various preclinical squamous cell carcinoma models SAN FRANCISCO, … Read more

Visgenx to present at the American Society of Gene and Cell Therapy 2023 Annual Meeting

Poster presentation covers data on VGX-0111, the Company’s gene therapy candidate for Dry Age-related Macular Degeneration (AMD), an aging related disorder and a leading cause of vision loss SAN DIEGO, May 15, 2023 /PRNewswire/ — Visgenx, Inc., a biotechnology company focused on developing gene therapies for degenerative retinal diseases, today announced that the Company will … Read more

Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research

LONDON, May 15, 2023 /PRNewswire/ — Acute repetitive seizures are an affliction that can strike fear into the hearts of those who suffer from them. These seizures are characterized by recurrent bouts of convulsions, muscle spasms, and loss of consciousness, all of which can happen multiple times in a short span of time. The condition can … Read more

Rippl Appoints Industry Leading CEOs to Board Bringing Significant New Experience in Tech-enabled, Value-based Services and Senior-focused Mental and Behavioral Health

Innovators Iyah Romm, Co-Founder and former CEO of Cityblock Health, and Ryan Watts, Co-Founder and CEO of Denali Therapeutics, poised to Help Rippl Transform care for seniors with neurocognitive challenges SEATTLE, May 15, 2023 /PRNewswire/ — Rippl, a new kind of behavioral health company focused on dramatically expanding access to high quality, wrap-around care for … Read more

Report Forecasts Promising Future for Alzheimer’s Disease Market with New Therapeutic Approaches

LONDON, May 15, 2023 /PRNewswire/ — Alzheimer’s disease is a devastating neurodegenerative disorder that affects millions of people worldwide. As the population ages, the incidence of Alzheimer’s disease is expected to rise, creating a growing need for effective treatments. This presents a significant opportunity for the development of innovative therapies that can improve the lives of … Read more

NUCLIDIUM and PharmaLogic Form Strategic Partnership for Sustainable Development of Novel Copper-based Theranostics to Diagnose and Treat Solid Tumours

Collaboration agreement strengthens 61Cu-supply chain capabilities for clinical development in North America BASEL, Switzerland and BOCA RATON, Fla., May 15, 2023 /PRNewswire/ — NUCLIDIUM and PharmaLogic Holdings today announced that they have entered into a strategic collaboration agreement for the production and clinical supply of 61Cu in the United States to accelerate the development of … Read more

Institute for TCIM/CAM to organize World Health Congress 2023 in Prague

PRAGUE, May 15, 2023 /PRNewswire/ — On 15–17 September, Prague will become the world center of traditional, complementary, integrative and alternative medicine (TCIM/CAM). Prague will be the venue of the 3rd World Health Congress 2023 Prague www.whc2023prague.com. The motto of this year’s Congress edition is: Accomplishments and current trends in TCIM for the 21st century – … Read more

Optimum Hires Senior Journalist Stephen Adams, Former Medical Editor of The Mail on Sunday

LONDON, May 15, 2023 /PRNewswire/ — Optimum Strategic Communications (“Optimum”), the specialist life sciences communications consultancy, today announces the appointment of highly-experienced medical journalist, Stephen Adams, as a full-time member of its team. Stephen, who joins as an Associate Director with immediate effect, spent 10 years at The Mail on Sunday, first as Health Correspondent … Read more

TVM Capital Healthcare opens office in Riyadh, Saudi Arabia

DUBAI, UAE and RIYADH, Saudi Arabia, May 15, 2023 /PRNewswire/ — TVM Capital Healthcare, a global specialist healthcare private equity  firm operating in emerging markets, announced today the opening of a new office in the capital of the Kingdom of Saudi Arabia. The purpose of the new office is to advise the group and its portfolio … Read more

MGI Empowers the Completion of Nearly 60,000 Samples for The Million Microbiome of Humans Project

SHENZHEN, China, May 15, 2023 /PRNewswire/ — MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, recently shared that a total of nearly 60,000 samples have been sequenced among 21 institutes and over 10 participating nations throughout Europe, as part of the Million Microbiome of Humans … Read more